Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Thomas

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|July 5, 2005
Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activitiesBrian F Thomas, Maria Elena Y Francisco, Herbert H Seltzman, et al.
Journal of Medicinal Chemistry|August 3, 2016
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic PainHerbert H Seltzman, Craig Shiner, Erin E Hirt, et al.
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 2015
AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in MiceJenny L Wiley, Julie A Marusich, Timothy W Lefever, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 27, 2012
Dose-response effects of spectrum research cigarettesDorothy K Hatsukami, Stephen J Heishman, Rachel Isaksson Vogel, et al.
Journal of Analytical Toxicology|May 15, 2012
Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoidsAnderson O Cox, Richard C Daw, Michele D Mason, et al.
Journal of Medicinal Chemistry|July 17, 2013
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528)Evangelia Kotsikorou, Frank Navas, Michael J Roche, et al.
The American Journal of Clinical Nutrition|October 26, 2002
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal womenLeAnne T Bloedon, A Robert Jeffcoat, Wlodek Lopaczynski, et al.
The American Journal of Clinical Nutrition|January 5, 2002
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy menMarjorie G Busby, A Robert Jeffcoat, LeAnne T Bloedon, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|July 5, 2005
Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activitiesBrian F Thomas, Maria Elena Y Francisco, Herbert H Seltzman, et al.
Journal of Medicinal Chemistry|August 3, 2016
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic PainHerbert H Seltzman, Craig Shiner, Erin E Hirt, et al.
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 2015
AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in MiceJenny L Wiley, Julie A Marusich, Timothy W Lefever, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 27, 2012
Dose-response effects of spectrum research cigarettesDorothy K Hatsukami, Stephen J Heishman, Rachel Isaksson Vogel, et al.
Journal of Analytical Toxicology|May 15, 2012
Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoidsAnderson O Cox, Richard C Daw, Michele D Mason, et al.
Journal of Medicinal Chemistry|July 17, 2013
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528)Evangelia Kotsikorou, Frank Navas, Michael J Roche, et al.
The American Journal of Clinical Nutrition|October 26, 2002
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal womenLeAnne T Bloedon, A Robert Jeffcoat, Wlodek Lopaczynski, et al.
The American Journal of Clinical Nutrition|January 5, 2002
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy menMarjorie G Busby, A Robert Jeffcoat, LeAnne T Bloedon, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Pageof 9